Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study

They reduce appetite and slow down digestion. Users decrease with weight loss syringes. However, the active ingredient increasingly allows people to access other foods as well. The effect could have an impact on food manufacturers.

MetaVia Announces Positive Top-Line Data From the 4-Week Phase 1 MAD Trial of DA-1726, a Novel 3:1 Ratio GLP-1 Glucagon Dual Receptor Agonist to Treat Obesity, Showing Compelling Weight Loss and Safety Effects With Potential Best-In-Class Glucose Control

With No Titration, Demonstrated Compelling Maximum Weight Loss of 6.3% and

Study captures sharp uptake in use of new weight loss and glucose-lowering medications

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study

76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits

Sharp rise in use of new GLPs as metformin, sulfonylureas and insulin declines

Investigators from Mass General Brigham who examined claims data from nearly two million people between 2021 and 2023, have reported a shifting landscape for weight loss and glucose-managing medications, including a increase in the use of newly approved medications, whilst the use of medications previously common in the treatment of type 2 diabetes (including metformin, sulfonylureas and insulin) decreased."Taken together, these findings highlig…

Study shows consumers taking GLP-1s for weight loss increase produce purchases

Jacksonville, Fla. (April 14, 2025) – In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss.Among several new insights for brands and retailers, the study reflects that consumers are taking these medications for relatively short periods of time. …